Second, Dr. Aboyans and colleagues raise the issue of residual confounding. We performed a rigorous adjustment for potential confounders, including cardiovascular risk factors (age, sex, systolic blood pressure, hypertension, smoking, body mass index, and diabetes), comorbidities (coronary heart disease, cerebrovascular disease, congestive heart failure, chronic kidney disease, malignancy, and chronic obstructive pulmonary disease), medication use (statins and aspirin), and the presence of critical limb ischemia. The hypothesis that patients with PCA may not have been treated as aggressively as patients with PAD is interesting and will need to be addressed in future studies. With regard to the duration of diabetes, this is difficult to ascertain accurately, even in prospective studies, given the often long pre-symptomatic stage for this disease.